Protalix BioTherapeutics (PLX) Reports FY Loss of $0.08
Tweet
Share
E-mailGet Alerts PLX Hot Sheet
Price: $2.84 +3.27%
EPS Growth %: -266.7%
Financial Fact:
NET LOSS FOR THE PERIOD: -7.29M
Today's EPS Names:
OCCI, ALZN, ASPU, More
EPS Growth %: -266.7%
Financial Fact:
NET LOSS FOR THE PERIOD: -7.29M
Today's EPS Names:
OCCI, ALZN, ASPU, More
Join SI Premium – FREE
Protalix BioTherapeutics (NYSE: PLX) reported FY EPS of ($0.08). Revenue for the period came in at $52.74 million.
For earnings history and earnings-related data on Protalix BioTherapeutics (PLX) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- KB Home (KBH) Tops Q3 EPS by 16c
- MillerKnoll, Inc. (MLKN) Tops Q1 EPS by 18c ; Offers Guidance
- BMO Capital Starts HCA Healthcare Inc (HCA) at Outperform
Create E-mail Alert Related Categories
EarningsRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
